EU Health Commissioner Paves the Way for Faster Medical Device Regulation Reforms

EU Medical Device Regulations Undergoing Accelerated Review

EU Health Commissioner Olivér Várhelyi has confirmed that the review of the EU’s medical device regulations will take place sooner than originally anticipated. This shift marks a significant change in the European Commission’s stance, as it had previously refrained from committing to early revisions. The regulations, introduced in 2017, cover a broad range of medical products, including X-ray machines, pacemakers, contact lenses, and bandages. However, delays in implementation and concerns over safety gaps have highlighted the urgent need for reassessment. The European Commission has now pledged to initiate consultations and move forward with a potential review well before the original deadline of May 2027.

Urgent Actions to Address Medical Device Market Bottlenecks

In the immediate term, Várhelyi emphasized that the Commission will focus on resolving critical bottlenecks in the EU medical device market, particularly delays affecting orphan medical devices, including those essential for paediatric care. A leaked draft of the Commission’s working program suggests that these measures will be introduced within the first 100 days of the new Commission’s term. The goal is to streamline medical device approval processes, addressing slow product compliance designations that have led to shortages of essential treatments. Additionally, the Commission aims to reduce bureaucratic hurdles and lower costs for notifying bodies to ensure quicker market access for vital products.

Stakeholder Perspectives: Balancing Reform Speed and Safety

While MedTech Europe, representing EU medical device manufacturers, advocates for swift regulatory reforms, not all stakeholders agree on the pace of implementation. The European Patients’ Forum (EPF) has urged caution, emphasizing the need for thorough impact assessments before making regulatory changes. Similarly, a European Parliament resolution passed in October supported reform proposals but stressed that modifications must be grounded in sound evidence. Politically, the centre-right European People’s Party (EPP) is pushing for faster reforms, whereas liberal, green, and socialist groups insist that patient safety and regulatory effectiveness must remain the top priorities.